Evolution of the lipoprotein gene in the enterobacteriaceae. Cloning and DNA sequence of the lpp gene from Proteus mirabilis

We cloned the lipoprotein gene from Proteus mirabilis and determined its DNA sequence. Comparison with the lpp genes from Escherichia coli, Serratia marcescens, Erwinia amylovora and Morganella morganii revealed several unique features of the evolution of the lpp gene in the Enterobacteriaceae and enabled us to establish phylogenetic relationships between these bacteria.     

The expression of a highly expressed Bacillus subtilis gene is not reduced by introduction of multiple codons normally not present in such genes

A recombinant DNA Proteus mirabilis L-form expression system, LVI (pJS127), was used to synthesize human fusion interferon alpha 1 (f-IFN-alpha 1). In the expression plasmid used, the complete coding sequence of IFN-alpha 1 was linked to the streptococcal speA promoter and the 5' end of the speA structural gene including its signal sequence coding region. LVI (pJS127) was capable of complete secretion into the culture medium of biologically active f-IFN-alpha 1 whose identity was confirmed by immunological and chemical evidence. In particular, bacterial L-forms were for the first time shown to be capable of correct signal peptide processing, as determined by N-terminal sequencing of the secreted f-IFN.     

Structural and immunochemical studies on the lipopolysaccharide of the ‘T-antigen’-containing mutant Proteus mirabilis R14/1959

Abstract In DOC-PAGE, lipopolysaccharide (LPS) of Proteus mirabilis R14/1959 (Rb-type) mutant showed a ladder-like migration pattern indicating the presence of a high molecular weight polysaccharide chain. The isolated polysaccharide, called T-antigen because of similarity with the T1 chain of Salmonella friedenau LPS, contained d -glucose, d -galacturonic acid ( d -GalA), and d -GlcNAc in molar ratios 2:1:1 and was structurally different from the O-antigen of the parental S-strain P. mirabilis S1959 but identical to the O-antigen of another S-strain Proteus penneri 42. The importance of a d -GalA( l -Lys)-containing epitope, most likely present in the core region of LPS, and of GalA present in the T-antigen chain in manifesting the serological specificity of P. mirabilis R14/1959 were revealed using rabbit polyclonal homologous and heterologous R- and O-specific antisera and the appropriate antigens, including synthetic antigens which represent partial structures of various Proteus LPS.     

尿液中奇异变形杆菌耐药性变迁及监测分析

目的了解尿液中奇异变形杆菌临床分布及耐药性变迁情况,为临床医生合理选用抗生素提供理论依据。方法收集2008年至2012年住院及门诊患者尿液标本中分离的215株奇异变形杆菌,采用VITEK2 Compact全自动微生物分析仪进行鉴定及药敏试验,采用WH0NET 5.4软件进行统计分析。结果2008、2009、2010、2011和2012年分离奇异变形杆菌分别为26株（占12. 2% ）、26株（占12.2% ）、36株（占16. 9% ）、55株（占25. 8% ）和72株（占33. 8% ）,总计215株。奇异变形杆菌对呋喃妥因的耐药率最高,均〉90%,对丁胺卡那霉素和美洛培南的耐药率最低,均为0%,对左旋氧氟沙星的耐药率在2008？2011年均〉50% ,2012年为28.1% ;对哌拉西林/他唑巴坦的耐药率在2008 - 2009年均〉20%,而2010-2012年均〈5% ;头孢替坦、舒普深耐药率均〈7%。结论奇异变形杆菌的分离率从2008 -2012年呈日益增长趋势,提醒我们随着临床上大量使用抗生素,医院的感染率亦不断上升。耐药率从2008-2011年基本呈上升趋势,而在2012年有所下降,这可能与近几年本院临床严格执行抗菌药物的合理应用有关。     

Fimbriae of uropathogenic Proteus mirabilis

Proteus mirabilis is a common causative agent of cystitis and pyelonephritis in patients with urinary catheters or structural abnormalities of the urinary tract. Several types of fimbriae, which are potentially involved in adhesion to the uroepithelium, can be expressed simultaneously by P. mirabilis: mannose-resistant/Proteus-like (MR/P) fimbriae, P. mirabilis fimbriae (PMF), uroepithelial cell adhesin (UCA), renamed by some authors nonagglutinating fimbriae (NAF), and ambient-temperature fimbriae (ATF). Proteus mirabilis is a common cause of biofilm formation on catheter material and MR/P fimbriae are involved in this process. The considerable serious pathology caused by P. mirabilis in the urinary tract warrants the development of a prophylactic vaccine, and several studies have pointed to MR/P fimbriae as a potential target for immunization. This article reviews P. mirabilis fimbriae with regard to their participation in uropathogenesis, biofilm formation and as vaccine targets.     

同株奇异变形杆菌存在不同生长状态

揭示同株奇异变形杆菌存在多种不同的生长状态。通过环形接种、点种传代、革兰染色和鞭毛染色等方法观察同株奇异变形杆菌的形态学变化。同株奇异变形杆菌的生长速度、迁徙能力、生长形态及鞭毛形态发生变化。同株奇异变形杆菌存在不同的生长形态。     

一株转化大豆苷元为S-雌马酚菌株的筛选和鉴定

【目的】筛选一株可转化大豆苷元为S-雌马酚的微生物菌株,并对该菌株进行鉴定。【方法】在厌氧条件下采用抗生素抑制非目标菌生长并结合稀释涂平板法进行菌株分离,分离可转化大豆苷元生成S-雌马酚的肠道细菌,并对产物进行结构鉴定。之后通过16S rDNA序列分析,构建该菌系统进化树,结合菌体形态及菌落特征,确立该菌系统发育学地位。【结果】从大鼠肠道内筛选分离到一株可以将大豆苷元转化为S-雌马酚的革兰氏阴性兼性厌氧菌株LH-52(JN861767),16S rDNA序列测序结果 BLAST比对表明该菌株与奇异变形杆菌(Proteus mirabilis)相似度达到了99%,结合形态特征和生理生化实验结果鉴定该菌为奇异变形杆菌。根据HPLC保留时间、质谱、核磁共振等波谱数据分析确定产物为S-雌马酚。【结论】菌株P.mirabilis LH-52为首次筛选到的可转化大豆苷元为S-雌马酚的兼性厌氧菌,相对于文献报道的严格厌氧菌更适合于工业化生产。